Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort
Université de Bordeaux · Institut Gustave Roussy · +16 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
255
total citations
- FWCI
- 36.41
- Percentile
- 100%
- References
- 26
Citations per year
Authors
21- AIAntoîne ItalianoCorresponding
Université de Bordeaux, Institut Gustave Roussy, Bordeaux Population Health, Institut Bergonié
- ABAlban Bessede
- MPM. Pulido
Inserm, Clinical Investigation Center Plurithematic Tours, Institut Bergonié, Centre d'Investigation Clinique Plurithématique de Bordeaux
- EBEmmanuelle Bompas
Institut de Cancérologie de l'Ouest
- SPSophie Piperno‐Neumann
Institut Curie
Topics & keywords
Topics
Keywords
- Pembrolizumab
- Medicine
- Internal medicine
- Clinical endpoint
- Oncology
- Soft tissue sarcoma
- Nausea
- Cohort
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.